Merck | MRK - Equity Capital And Reserves


Merck reported EUR29.74B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Adidas EUR 5.96B 31M Jun/2026
Adyen EUR 5.29B 610.33M Dec/2025
Akzo Nobel EUR 4.85B 28M Jun/2026
Alcon AG USD 22.13B 99M Mar/2026
Amadeus IT EUR 4.57B 229.6M Jun/2026
Amarin USD 443.62M 5.8M Jun/2026
AstraZeneca USD 50.3B 2.96B Jun/2026
BASF EUR 36.32B 846M Jun/2026
Bayer EUR 28.85B 2.9B Mar/2026
Beiersdorf EUR 8.6B 133M Dec/2025
Covestro EUR 7B 908M Dec/2025
Danone EUR 16.61B 308M Jun/2026
Fresenius EUR 20.46B 698M Mar/2026
Fresenius Medical Care EUR 14.2B 13.95B Mar/2026
Genmab DKK 5.85B 96M Dec/2025
Givaudan CHF 4.54B 430M Dec/2025
GlaxoSmithKline GBP 17.64B 223M Jun/2026
GRIFOLS EUR 7.98B 2.52B Jun/2026
Henkel EUR 20.5B 459M Dec/2025
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Infineon EUR 17.42B 629M Jun/2026
Lakefront Biotherapeutics EUR 3.25B 17.5M Mar/2026
Linde USD 40.09B 1.85B Mar/2026
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 29.74B 1.15B Mar/2026
Novartis USD 41.95B 3.02B Jun/2026
Philips EUR 11.48B 84M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sanofi EUR 69.57B 3.24B Jun/2026
UCB EUR 10.87B 1.18B Dec/2025